PAMELA BECKER: Open Payments
NPI 1255714531 · EATON RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,942 in 96 payments from 16 companies in 2025. Trend: 2023 $234 · 2024 $1,306 · 2025 $1,942
Food & beverage: $1,942
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $411 |
| ABBVIE INC. | 13 | $381 |
| Novo Nordisk Inc | 10 | $246 |
| Amgen Inc. | 16 | $228 |
| Otsuka America Pharmaceutical, Inc. | 7 | $187 |
| Axsome Therapeutics, Inc. | 10 | $177 |
| AstraZeneca Pharmaceuticals LP | 5 | $104 |
| PFIZER INC. | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| Abbott Laboratories | 1 | $22 |
Products named: CAPLYTA, QULIPTA, REXULTI, Ozempic, Auvelity, REPATHA, OTEZLA, AIRSUPRA.
Industry payments across MI — which companies pay providers there.
